Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
China Mulls New Reform Approaches as Healthcare Expenditure Growth Tamed in 2013
Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this month's emphasis on latest official data releases, government healthc... (7/18/2014)
   
China Mulls New Reform Approaches as Healthcare Expenditure Growth Tamed in 2013 (7/18/2014)
Another Twist in the Ongoing GSK-China Scandal (7/15/2014)
More Inside Stories of GSK Scandal Emerges As Hired British Private Eye Faces Trial (External) (7/4/2014)
Confusing Messages For Investors and Multinationals From China's Healthcare Reforms (7/2/2014)
Chinese Government Maintains High Pressure on MNCs as It Pushes Forward Healthcare Reform Priorities (6/24/2014)
Embracing China's Brave New Pharmaceutical World (6/13/2014)
Understanding China's Antimonopoly Investigations (External) (6/12/2014)
China: China's Evolving Legal Landscape For Trade Secret Protection (External) (6/11/2014)
GSK Salesmen Want 'Bribes' Reimbursed (5/28/2014)
A Bitter Pill as China Crackdowns Squeeze Pharma Margins (External) (5/26/2014)
China's Big Pharma Probe: The Lead-Up to This Week's Latest Move (5/23/2014)
MNCs Left in Disarray as Hard-nosed Government Seeks to Re-energize Healthcare Reform (5/22/2014)
China Set to Widen Drug Probes (External) (5/20/2014)
Foreign Businesses Act after GSK Probe (External) (5/19/2014)
The GSK Crackdown Takes A Very Personal Turn (External) (5/16/2014)
China and Asian Market Growth Drove Nova...  (7/21/2014)
CFDA Issues Technical Guidelines for Pha...  (7/21/2014)
Financial-related Company News in Brief  (7/18/2014)
Abbvie to Acquire Shire for US$55 Billio...  (7/18/2014)
Recent Executive Moves  (7/18/2014)
Recent CFDA Official Moves  (7/18/2014)
China to Put GSK-linked Investigators on...  (7/17/2014)
NHFPC Issues Notice to Push Forward Majo...  (7/17/2014)
CFDA Vice Minister Wu Zhen meets CEO of ...  (7/17/2014) (free)
Three Former GSK Employees File Labor Ar...  (7/17/2014)
US Officials Review GSK China's Vaccine ...  (7/17/2014)
GW and PKU Medical Division Receive Gran...  (7/16/2014) (free)
Chinese Pharma Cos Eye Czech Republic fo...  (7/16/2014)
CFDA Issues Guidelines for Drug Quality ...  (7/15/2014)
Shanghai to Introduce Policies for Promo...  (7/15/2014) (free)
Abbvie to Acquire Shire for US$55 Billion
Survey: Smartphones Preferred Healthcare Communication C...
Shire Rejects Takeover Offer from Abbvie
Merck, Sanofi, Glaxo Move to Unload Older Drugs
Pfizer Ends Takeover Bid for AstraZeneca
Chinese Animal Vaccine Market to Continue Double-digit Growth B...
Nicholas Hall: Chinese OTC Drug Market Maintained Steady Growth...
IMS: Chinese Hospital Drug Market Continued Double-Digit Growth...
IMS: Chinese Urban Retail Pharmacy Market Growth Up in 2013
Chinese Market for Facial Injectables to Expand 20% CAGR thru 2...
China and Asian Market Growth Drove Novartis Performance in ...
Financial-related Company News in Brief
Chinese Pharma Cos Eye Czech Republic for EU Entry
Shanghai to Introduce Policies for Promotion of Biopharma In...
List of Chinese Pharma/Healthcare Companies in 2014 Fortune ...
CFDA Issues Technical Guidelines for Pharmacokinetics of...
CFDA Issues Guidelines for Drug Quality Sampling and Ana...
China's Vaccine Regulatory System Passes WHO Reassessmen...
Multiple Provincial Level Governments Introduce Low-Cost...
CFDA Minister Zhang Yong Meets EU Commissioner Neven Mim...
China to Put GSK-linked Investigators on Public Trial Follow...
Three Former GSK Employees File Labor Arbitration Complaints...
US Officials Review GSK China's Vaccine Bribery Scandal in 2...
China Confirms Trial of Private Investigators Linked to GSK
China Brushes Off U.S. Concern over Closed Trial of GSK-Link...
Study: India Heavily Dependent on China for Essential AP...
FDA Issues Warning Letter to Tianjin Zhongan Pharmaceuti...
Snapshot Review of the Chinese Vitamins Industry – Oppo...
Chinese API Export Sales Falls Further in Q1/2014
US Group for Pharma Supply Chain Security to Increase Ac...
GW and PKU Medical Division Receive Grant to Study Commo...
Beike Biotech's Stem Cell Treatment IND Accepted for Fin...
Pharmalink Granted Chinese and Other Patents for Renal O...
Uni-Bio's Once-Daily Osteoporosis Drug Meets Phase III P...
Humanwell Cleared by CFDA for Phase I Trial of Class 1.1...
NHFPC Issues Notice to Push Forward Major Tasks for Rura...
NHFPC Wants Medical Liability Insurance in Most Hospital...
World Bank and Chinese Government to Jointly Produce Maj...
NHFPC Mulls New Approach for Classified Hospital Drug Pu...
Is Post-tender Secondary Negotiation Back with New Munic...
Recent Executive Moves
Recent CFDA Official Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
CFDA Vice Minister Wu Zhen meets CEO of the GAVI Allianc...
Upcoming Event: 6th Annual BioProcess International Chin...
Upcoming Event: 6th Annual Partnerships in Clinical Tria...
Upcoming Event: Pharmacon - Pharmaceutical Congress Asia...
Upcoming Event: Annual Single Cell Genomics & Transc...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
  Pharma China adds another dist...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links